Given this pathway, and given that "Selective serotonin reuptake inhibitors (SSRIs) are some of the most prescribed drugs in the world," we should be seeing inverse correlation between increases in prescription of fluoxetine and heart disease (outside of larger novel or growing factors causing heart disease, of course).
I wonder what the research looks like in that space...
Given this pathway, and given that "Selective serotonin reuptake inhibitors (SSRIs) are some of the most prescribed drugs in the world," we should be seeing inverse correlation between increases in prescription of fluoxetine and heart disease (outside of larger novel or growing factors causing heart disease, of course).
I wonder what the research looks like in that space...